FSLY News

After a busy week in the IPO market, just one biotech is scheduled to go public in the week ahead. NASH biotech 89bio (ETNB) plans to raise $85 million at a $225 million market cap. The company’s target indication represents a multi-billion-dollar market with no FDA-approved therapy; consequently, there are ...read more

In the first busy week since the August break, six companies and two SPACs entered the public market. VC-backed health and tech fared well, led by 10x Genomics (TXG) and Cloudflare (NET), while SmileDirectClub (SDC) saw its initial hype evaporate. The largest deal of the week, SmileDirectClub (SDC)...read more

After the busiest week of the year in the prior week, May 2019 continued to be active this past week with five IPOs and one SPAC offering. Three came to market with valuations of more than $1 billion, including fast-growing unicorns Luckin Coffee and Fastly, and Avantor, the largest IPO of an LBO'd company since 2011. Avantor (AVTR), an LBO'd...read more

Fastly, which operates an edge cloud platform for optimized web and application delivery, raised $180 million by offering 11.25 million shares at $16, the high end of the range of $14 to $16. The San Francisco, CA-based company plans to list on the NYSE under the symbol FSLY. BofA Merrill Lynch, Citi and Credit Suisse acted as lead managers on the deal. ...read more